These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 11979370)

  • 41. The localization of transforming growth factor alpha and epidermal growth factor receptor in stromal and epithelial compartments of developing human prostate and hyperplastic, dysplastic, and carcinomatous lesions.
    Leav I; McNeal JE; Ziar J; Alroy J
    Hum Pathol; 1998 Jul; 29(7):668-75. PubMed ID: 9670822
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Telomerase reverse transcriptase subunit immunoreactivity: a marker for high-grade prostate carcinoma.
    Iczkowski KA; Pantazis CG; McGregor DH; Wu Y; Tawfik OW
    Cancer; 2002 Dec; 95(12):2487-93. PubMed ID: 12467061
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunohistochemical comparative analysis of transforming growth factor alpha, epidermal growth factor, and epidermal growth factor receptor in normal, hyperplastic and neoplastic human prostates.
    De Miguel P; Royuela ; Bethencourt R; Ruiz A; Fraile B; Paniagua R
    Cytokine; 1999 Sep; 11(9):722-7. PubMed ID: 10479409
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ghrelin and a novel preproghrelin isoform are highly expressed in prostate cancer and ghrelin activates mitogen-activated protein kinase in prostate cancer.
    Yeh AH; Jeffery PL; Duncan RP; Herington AC; Chopin LK
    Clin Cancer Res; 2005 Dec; 11(23):8295-303. PubMed ID: 16322288
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nuclear localization of androgen receptor in heterogeneous samples of normal, hyperplastic and neoplastic human prostate.
    Chodak GW; Kranc DM; Puy LA; Takeda H; Johnson K; Chang C
    J Urol; 1992 Mar; 147(3 Pt 2):798-803. PubMed ID: 1371552
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Diallyl trisulfide-induced apoptosis in human prostate cancer cells involves c-Jun N-terminal kinase and extracellular-signal regulated kinase-mediated phosphorylation of Bcl-2.
    Xiao D; Choi S; Johnson DE; Vogel VG; Johnson CS; Trump DL; Lee YJ; Singh SV
    Oncogene; 2004 Jul; 23(33):5594-606. PubMed ID: 15184882
    [TBL] [Abstract][Full Text] [Related]  

  • 47. C-Jun N-terminal kinase is required for phorbol ester- and thapsigargin-induced apoptosis in the androgen responsive prostate cancer cell line LNCaP.
    Engedal N; Korkmaz CG; Saatcioglu F
    Oncogene; 2002 Feb; 21(7):1017-27. PubMed ID: 11850819
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cytoskeletal and cytocontractile protein composition of stromal tissue in normal, hyperplastic, and neoplastic human prostate. An immunocytochemical study with monoclonal antibodies.
    Castellucci E; Prayer-Galetti T; Roelofs M; Pampinella F; Faggian L; Gardiman M; Pagano F; Sartore S
    Ann N Y Acad Sci; 1996 Apr; 784():496-508. PubMed ID: 8651605
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MEK5 overexpression is associated with metastatic prostate cancer, and stimulates proliferation, MMP-9 expression and invasion.
    Mehta PB; Jenkins BL; McCarthy L; Thilak L; Robson CN; Neal DE; Leung HY
    Oncogene; 2003 Mar; 22(9):1381-9. PubMed ID: 12618764
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of roles of three mitogen-activated protein kinases induced by chromium(VI) and cadmium in non-small-cell lung carcinoma cells.
    Chuang SM; Yang JL
    Mol Cell Biochem; 2001 Jun; 222(1-2):85-95. PubMed ID: 11678615
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Caspase 3 expression in benign prostatic hyperplasia and prostate carcinoma.
    O'Neill AJ; Boran SA; O'Keane C; Coffey RN; Hegarty NJ; Hegarty P; Gaffney EF; Fitzpatrick JM; Watson RW
    Prostate; 2001 May; 47(3):183-8. PubMed ID: 11351347
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Gonadotropin-releasing hormone induces apoptosis of prostate cancer cells: role of c-Jun NH2-terminal kinase, protein kinase B, and extracellular signal-regulated kinase pathways.
    Kraus S; Levy G; Hanoch T; Naor Z; Seger R
    Cancer Res; 2004 Aug; 64(16):5736-44. PubMed ID: 15313914
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunoreactivity to caspase-3, caspase-7, caspase-8, and caspase-9 forms is frequently lost in human prostate tumors.
    Rodríguez-Berriguete G; Galvis L; Fraile B; de Bethencourt FR; Martínez-Onsurbe P; Olmedilla G; Paniagua R; Royuela M
    Hum Pathol; 2012 Feb; 43(2):229-37. PubMed ID: 21802116
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Regulation of proliferation and differentiation of prostatic stromal cells by oestradiol through prostatic epithelial cells in a paracrine manner.
    Wu Q; Shi J; Chen L; Wang CY; Park I; Lee C; Zhang J
    BJU Int; 2008 Feb; 101(4):497-502. PubMed ID: 18190643
    [TBL] [Abstract][Full Text] [Related]  

  • 55. MAP kinase activation and apoptosis in lung tissues from patients with idiopathic pulmonary fibrosis.
    Yoshida K; Kuwano K; Hagimoto N; Watanabe K; Matsuba T; Fujita M; Inoshima I; Hara N
    J Pathol; 2002 Nov; 198(3):388-96. PubMed ID: 12375272
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mitogen-activated protein kinases and retinal ischemia.
    Roth S; Shaikh AR; Hennelly MM; Li Q; Bindokas V; Graham CE
    Invest Ophthalmol Vis Sci; 2003 Dec; 44(12):5383-95. PubMed ID: 14638742
    [TBL] [Abstract][Full Text] [Related]  

  • 57. 5-Lipoxygenase expression in benign and malignant canine prostate tissues.
    Goodman LA; Jarrett CL; Krunkosky TM; Budsberg SC; Northrup NC; Saba CF; LeRoy BE
    Vet Comp Oncol; 2011 Jun; 9(2):149-57. PubMed ID: 21569200
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Expression and significance of caspase-1 in benign hyperplastic prostate tissues].
    Deng CH; Zang ZJ; Sun XZ; Huang XH; Wang H; Wang D; Su SH
    Zhonghua Nan Ke Xue; 2005 Nov; 11(11):810-2. PubMed ID: 16333955
    [TBL] [Abstract][Full Text] [Related]  

  • 59. c-Jun NH2-terminal kinase-dependent Fas activation contributes to etoposide-induced apoptosis in p53-mutated prostate cancer cells.
    Shimada K; Nakamura M; Ishida E; Kishi M; Yonehara S; Konishi N
    Prostate; 2003 Jun; 55(4):265-80. PubMed ID: 12712406
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Expression of protein kinase C isoenzymes in benign hyperplasia and carcinoma of prostate.
    Koren R; Ben Meir D; Langzam L; Dekel Y; Konichezky M; Baniel J; Livne PM; Gal R; Sampson SR
    Oncol Rep; 2004 Feb; 11(2):321-6. PubMed ID: 14719062
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.